In summary, our study revealed that global reduction of Atp5b could protect mice from diet-induced obesity and hyperlipidemia likely by enhancing lipolysis and inhibiting de novo lipogenesis. The gene discussed is ATP5F1B; the disease is obesity due to melanocortin 4 receptor deficiency.